Q4 2020 Holdings
Filed 2021-02-16 | 96 holdings | $860.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Inozyme Pharma Inc | COM | 45790W108 | $200 | 9,683 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $1.2K | 30,000 | 0.0% |
| American Well Corp | CL A | 03044L105 | $1.3K | 50,000 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $1.6K | 50,000 | 0.0% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $1.7K | 50,000 | 0.0% |
| Accolade Inc(ACCDEUR) | COM | 00437E102 | $1.7K | 40,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $2.7K | 50,000 | 0.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $2.8K | 40,000 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $3.1K | 92,574 | 0.0% |
| Bctg Acquisition Corp | COM | 05492W103 | $3.4K | 300,000 | 0.0% |
| Panacea Acquisition Corp | UNIT 99/99/9999 | 698102209 | $3.8K | 300,000 | 0.0% |
| Lifesci Acquisition II Corp | COM | 53229E103 | $4.3K | 400,000 | 0.0% |
| Helix Acquisition Corp | COM CL A | G4444C102 | $4.5K | 400,000 | 0.0% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $4.7K | 125,000 | 0.0% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $5.1K | 152,500 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $5.1K | 300,000 | 0.0% |
| Health Sciences ACQ Corp 2 | ORD SHS | G4411D109 | $5.1K | 400,000 | 0.0% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $5.2K | 250,000 | 0.0% |
| Arya Sciences Acquisition Co | COM CL A | G3166W106 | $5.4K | 500,000 | 0.0% |
| Bcls Acquisition Corp | COM CL A | G0904B105 | $5.6K | 500,000 | 0.0% |
| Outset MED Inc(OMGBP) | COM | 690145107 | $5.7K | 100,000 | 0.0% |
| Ligand Pharmaceuticals Inc(LGND) | COM NEW | 53220K504 | $6.2K | 62,100 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $7.1K | 80,000 | 0.0% |
| Vesper Healthcare Acqstn COR | UNIT 99/99/9999 | 92538T203 | $7.3K | 600,000 | 0.0% |
| Gritstone Oncology Inc(2JQ) | COM | 39868T105 | $8.4K | 2,122,064 | 0.0% |
| OAK STR Health Inc(OSH3EUR) | COM | 67181A107 | $9.2K | 150,000 | 0.0% |
| Scynexis Inc(SCYX) | COM NEW | 811292200 | $9.6K | 1,255,000 | 0.0% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $10.4K | 392,000 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $11.4K | 347,645 | 0.0% |
| Oncosec MED Inc | COM | 68234L306 | $12.6K | 1,952,000 | 0.0% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $13.0K | 270,000 | 0.0% |
| Harpoon Therapeutics Inc | COM | 41358P106 | $13.0K | 785,000 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $13.6K | 626,000 | 0.0% |
| Surgery Partners Inc(SGRY) | COM | 86881A100 | $15.4K | 531,000 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $15.5K | 125,690 | 0.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $15.7K | 1,248,000 | 0.0% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $16.5K | 303,000 | 0.0% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $17.1K | 965,300 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $17.5K | 5,726,000 | 0.0% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $17.8K | 4,000,000 | 0.0% |
| SI Bone Inc(SIBN) | COM | 825704109 | $19.1K | 639,884 | 0.0% |
| Curis Inc(CRISEUR) | COM NEW | 231269200 | $19.2K | 2,342,100 | 0.0% |
| Sotera Health Co(SHC) | COM | 83601L102 | $19.2K | 700,000 | 0.0% |
| Bioxcel Therapeutics Inc(BTAIEUR) | COM | 09075P105 | $25.3K | 547,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $26.9K | 240,000 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $27.3K | 578,100 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $28.8K | 300,000 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $30.5K | 2,558,000 | 0.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $32.7K | 247,000 | 0.0% |
| Sigilon Therapeutics Inc | COM | 82657L107 | $33.0K | 688,000 | 0.0% |